1. Home
  2. DGLY vs OGEN Comparison

DGLY vs OGEN Comparison

Compare DGLY & OGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DGLY
  • OGEN
  • Stock Information
  • Founded
  • DGLY N/A
  • OGEN 1996
  • Country
  • DGLY United States
  • OGEN United States
  • Employees
  • DGLY N/A
  • OGEN N/A
  • Industry
  • DGLY Radio And Television Broadcasting And Communications Equipment
  • OGEN Biotechnology: Pharmaceutical Preparations
  • Sector
  • DGLY Technology
  • OGEN Health Care
  • Exchange
  • DGLY Nasdaq
  • OGEN Nasdaq
  • Market Cap
  • DGLY 8.4M
  • OGEN 9.8M
  • IPO Year
  • DGLY N/A
  • OGEN N/A
  • Fundamental
  • Price
  • DGLY $2.15
  • OGEN $1.12
  • Analyst Decision
  • DGLY
  • OGEN
  • Analyst Count
  • DGLY 0
  • OGEN 0
  • Target Price
  • DGLY N/A
  • OGEN N/A
  • AVG Volume (30 Days)
  • DGLY 16.4K
  • OGEN 122.4K
  • Earning Date
  • DGLY 08-12-2024
  • OGEN 08-12-2024
  • Dividend Yield
  • DGLY N/A
  • OGEN N/A
  • EPS Growth
  • DGLY N/A
  • OGEN N/A
  • EPS
  • DGLY N/A
  • OGEN N/A
  • Revenue
  • DGLY $26,080,507.00
  • OGEN $20,629.00
  • Revenue This Year
  • DGLY $22.14
  • OGEN N/A
  • Revenue Next Year
  • DGLY N/A
  • OGEN N/A
  • P/E Ratio
  • DGLY N/A
  • OGEN N/A
  • Revenue Growth
  • DGLY N/A
  • OGEN N/A
  • 52 Week Low
  • DGLY $1.73
  • OGEN $0.97
  • 52 Week High
  • DGLY $4.40
  • OGEN $7.74
  • Technical
  • Relative Strength Index (RSI)
  • DGLY 39.07
  • OGEN 38.96
  • Support Level
  • DGLY $2.04
  • OGEN $1.00
  • Resistance Level
  • DGLY $2.45
  • OGEN $1.24
  • Average True Range (ATR)
  • DGLY 0.17
  • OGEN 0.08
  • MACD
  • DGLY -0.02
  • OGEN 0.02
  • Stochastic Oscillator
  • DGLY 25.41
  • OGEN 27.36

About DGLY Digital Ally Inc.

Digital Ally Inc produces digital video imaging and storage products for use in law enforcement, security, and commercial applications. Its products are an in-car digital video/audio recorder contained in a rear-view mirror for use in law enforcement and commercial fleets. It can integrate electronic, radio, computer, and multi-media technologies to create solutions to address needs in a variety of other industries and markets, including mass transit, school buses, taxicab, and military. The company sells its products directly to law enforcement agencies, security organizations, and consumer and commercial fleet operators both domestically and internationally through third-party distributors. Its segments include Video Solutions, Revenue Cycle Management, and Entertainment.

About OGEN Oragenics Inc.

Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's lead product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification.

Share on Social Networks: